Search

everythinglearnresearchcommunity

for

Search:↓

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Prolactin may be important for skin growth and immune function.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Check and treat low iron and vitamin D levels in people with hair loss.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A 6-year-old girl with Turner syndrome also had psoriasis, alopecia areata, and trachyonychia.

Adrenal disorders can cause lasting brain and behavior issues in children.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.